Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Eli Lilly is awaiting an FDA decision on a new indication for Mounjaro covering the reduction of major adverse cardiovascular events in patients with type 2 diabetes, supported by the SURPASS CVOT trial
While retatrutide is being developed primarily as an obesity and diabetes treatment, the triple-agonist mechanism has implications beyond weight loss
Those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 shouldnt get GLP-1 drugs
The bedtime timing matters because the goal is to amplify a pulse that would otherwise occur naturally during deep sleep, not to introduce a daytime pulse that conflicts with normal pituitary rhythms
Monthly photos in consistent lighting and poses reveal changes that numbers miss
